Paul Schmitt work email
- Valid
- Valid
Paul Schmitt personal email
Paul Schmitt phone numbers
A seasoned board member, CEO and venture capitalist, Paul Schmitt has a 35 year track record of successfully building companies and commercializing complex, regulated life science technologies, primarily in collaboration with top tier universities and academic medical centers. As a venture capitalist and CEO, he has raised over $500 million in growth capital financings and has led numerous transactions including IPO's, mergers, acquisitions, divestitures, licenses and joint ventures. In 2016 Mr. Schmitt formed New Street Ventures LLC and has invested in Mureva, Cernostics Inc, and SurgeonCheck LLC .New Street Ventures also provides advisory services to entrepreneurs and Health Care Systems seeking acquisitions and strategic partners.Paul currently serves on the Board of Directors at Mureva, Gelmed Sciences, JBS Animal Health II (J.V.) and as an Advisor and investor in SurgeonCheck LLC. In 2017 Mr Schmitt was named a Trustee Emeritus of the Wistar Institute of Anatomy and Biology where he served on the Board of Trustees since 2002 with service including Chair of the Intellectual Property and Business Development Committee, Nominating and Governance Committee and Audit Committee.
New Street Ventures Llc
-
FounderNew Street Ventures Llc May 2016 - PresentBethlehem PaNew Street Ventures has invested in MuReva,SurgeonCheck LLC,Cernostics and Bellrock Intelligence. Mr Schmitt is an active advisor to these companies and serves on the Board of Directors at Bellrock Intelligence and MuReva and as an Advisor to SurgeonCheck.www.surgeoncheck.com www.bellrockintel.com www.cernostics.comNew Street Ventures also provides advisory services to healthcare systems and entrepreneurs seeking acquisitions and strategic partners.
-
Managing DirectorNovitas Capital Jun 1999 - Aug 2018Bethlehem PaResponsible for directing all Life Science investments:-Led investments of $32 Million into 9 Fund III (2003- 2017)Life Science startups which attracted over $400Million in follow on capital.-Co-led formation of Tetralogic Pharmaceuticals out of Princeton Univ in 2003. Birinipant considered best in class for inhibition of SMAC Mimetics to treat infectious diseases,hematologic malignancies and solid tumors. IPO on 11/22/13 and follow on financing totaled $106 Million. Served on Board of Directors and as Chairman of the Audit Committee 2003-2015.-Led B Round financing in Renal Soloutions in 2004. Recruited Renal Industry luminary,Don Joseph to Board of Directors. Company sold to Fresenius Medical for $250Million in 2007.-Founding investor in Amorcyte and CEO, 2010-2012. In conjunction with Scientific/Clinical Founder launched Phase II randomized, double blind clinical trial in severe AMI,established dominant IP position for use of autologous CD34+/CXCR4+ cells in cardiovascular disease,quantified reimbursement strategy and completed merger with Neostem (NASDAQ:NBS).
-
ChairmanCernostics Inc Jun 2013 - Jun 2018Bethlehem, Pennsylvania
-
President/CeoAmorcyte 2010 - 2012Allendale NjRepresenting Novitas, Mr. Schmitt was a founding investor and CEO of Amorcyte, a cardiovascular stem cell therapy company founded out of Hackensack University Medical Center and Progenitor Cell Therapy Inc. As CEO, Mr. Schmitt and the Scientific /Clinical founder, Dr. Andrew Pecora, launched a phase II randomized, double blind clinical study in severe AMI patients, established a dominant IP position for use of autologous CD34+/CXCR4+ cells in cardiovascular disease, quantified a reimbursement strategy and completed a merger with Neostem (NASDAQ:NBS).
-
Chairman ,President,CeoChrysalis International 1995 - 1998Chief Executive Officer for Global CRO (NASDAQ:CRLS)providing transgenic, pre-clinical and clinical services to over 250 pharmaceutical and biotech clients in 23 countries.
-
PresidentNextran (Dnx/Baxter Healtcare J.V.) 1994 - 1995Princeton NjParallel to building Chrysalis, formed Nextran, a JV with Baxter Health Care and served as President and Board Member until its sale to Baxter in 1995. Nextran focused on utilizing DNX Corp. technology for genetically engineered swine as a source of blood substitutes and organs suitable for human transplant. Nextran completed the first successful ex-vivo transplants of genetically engineered pig livers to humans at Duke University in 1995.
-
President/CeoDnx Corporation 1988 - 1995Princeton NjRecruited to DNX Corp. to lead a venture funded startup in development and commercialization of transgenic animal technologies licensed from Founders/Academic Partners at Princeton University and Ohio University. DNX completed a B Round financing and IPO in 1991 raising $56MM largely based on successes in genetically engineering swine as a source of human blood substitutes and organs for transplant into humans.DNX was also a leader in utilizing transgenic technologies as a pre-clinical service business to identify and validate new human genetic targets of disease emerging from worldwide genomic initiatives.The transgenic services business provided a platform to aquire and grow additional pre-clinical and Phase I II III clinical companies into a Global CRO with over 250 Biotech/Pharmaceutical industry clients in 23 countries and operating companies in Lyon(FR),Dusseldorf (HR), Zug(Switz.) , Haifa (IL), Czech Republic, Austin Texas and Scranton Pa.This business was renamed Chrysalis International in 1996 and sold to Phoenix International in 1999.DNX's organ transplant and blood substitute technologies were merged into a Joint Venture,Nextran with Baxter Health Care in 1994. Nextran successfully completed the first ex-vivo transplants of genetically engineered pig livers to humans at Duke University in 1995 and was acquired by Baxter shortly thereafter.
-
PresidentBiolectron 1986 - 1988Hackensack NjMr, Schmitt was recruited to this fully integrated orthopedic company to lead commercialization of Orthopak,an electronic bone growth stimulator for long bone fractures which had a distribution agreement with Bristol Myers/Zimmer. In addition ,he conceived and launched a clinical program for high risk fresh fractures.
-
General Manager-Chief Executive, Ohmeda DveBoc Group 1981 - 1986Orchard Park, NyAs Chief Executive and General Manager, Mr Schmitt was responsible for leading the transformation of a low growth,unprofitable medical anesthesia and respiratory therapy business into two high growth emergency medical and dental airway management businesses. Transformational Emergency Medical and Trauma products were developed in collaboration with Dr. Ron Stewart,Director of EMS for the University of Pittsburgh Medical Center/City of Pittsburgh.
-
Director Strategic Planning-Health CareBoc Group 1980 - 1981Montvale Nj
-
Group Finance Manager- Health CareBoc Group 1979 - 1980Montvale Nj
-
Financial Analyst To Assistant Divisional ControllerNabisco Inc 1974 - 1979World Headquarters, East Hanover Nj1974-75 Financial Management Training program1975-76 Financial Analyst-Planning and Budgets1976-77 Financial Analyst-Capital Expenditures1977-78 Assistant Controller- Food Services Division
Paul Schmitt Skills
Paul Schmitt Education Details
Frequently Asked Questions about Paul Schmitt
What company does Paul Schmitt work for?
Paul Schmitt works for New Street Ventures Llc
What is Paul Schmitt's role at the current company?
Paul Schmitt's current role is Entrepreneur, Board Member,CEO,Venture CapitalNew Street Ventures LLC.
What is Paul Schmitt's email address?
Paul Schmitt's email address is ps****@****tal.com
What is Paul Schmitt's direct phone number?
Paul Schmitt's direct phone number is +161029*****
What schools did Paul Schmitt attend?
Paul Schmitt attended Lehigh University - College Of Business And Economics, Rutgers University - Newark.
What are some of Paul Schmitt's interests?
Paul Schmitt has interest in Children, Economic Empowerment, Education, Science And Technology, Health.
What skills is Paul Schmitt known for?
Paul Schmitt has skills like Venture Capital, Mergers And Acquisitions, Start Ups, Strategy, Lifesciences, Corporate Development, Management, Strategic Planning, Business Strategy, Commercialization, Due Diligence, Private Equity.
Not the Paul Schmitt you were looking for?
-
Paul Schmitt
Encinitas, Ca -
Paul Schmitt
Eugene, Or -
2bloomberg.net, serfiex.com -
Paul Schmitt
Bronx, Ny1dbibeverage.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial